Medicilon was selected as "2023 Science and Technology Innovation Board Hard and Core Technology Lea

Medicilon was selected as "2023 Science and Technology Innovation Board Hard and Core Technology Lea

A Story by Medicilon
"

On September 27, the "STAR Summit" was grandly held in Shanghai. The Summit announced the selection list for the fourth anniversary of science and technology innovation.

"

On September 27, the "STAR Summit" was grandly held in Shanghai.  The Summit announced the selection list for the fourth anniversary of science and technology innovation.

Shanghai Medicilon Inc (Medicilon) has been selected as a " 2023 Science and Technology Innovation Board Hard and Core Technology Leading Enterprise" based on its hard-core advantages in biopharmaceutical technology innovation over the years.

honor.webp

Technological innovation is the key to winning the future, and it is also what Medicilon is committed to pursuing.  Over the past 19 years, Medicilon has continued to increase investment in research and development, focusing on cutting-edge fields such as nucleic acid drugscellular immunitymRNA vaccinesPROTACADC, bi/multi-specific antibodies and established an innovative service platform to help promote the "hard core" of drugs.  In order to deepen the collaboration between the industry, academia and research institutions, Medicilon also established Medicilon Academician Innovation and Maturity Center, successfully signed the school-enterprise strategic collaboration with China Pharmaceutical University, and reached strategic collaboration with AI pharmaceutical companies such as Insilico Medicine and MindRank to assist the "hard-core" transformation of scientific and technological achievements.  In addition, Medicilon also strengthened the construction of scientific and technological innovation talent teams, deepen the reform of talent development systems and mechanisms, support young people to take up the leading role in scientific and technological innovation, and help the "hard-core" growth of talents.

© 2023 Medicilon


My Review

Would you like to review this Story?
Login | Register




Share This
Email
Facebook
Twitter
Request Read Request
Add to Library My Library
Subscribe Subscribe


Stats

94 Views
Added on October 24, 2023
Last Updated on October 24, 2023
Tags: CRO

Author

Medicilon
Medicilon

Cambridge, MA



About
Medicilon is an integrated contract research organization (CRO), providing comprehensive one-stop new drug R&D services for pharmaceutical enterprises and scientific research institutions around the w.. more..

Writing